Letters Guidance on osteoporosis

Confusion from analyses and conflicts of interest

BMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2683 (Published 25 November 2008) Cite this as: BMJ 2008;337:a2683
  1. J Lennert Veerman, research fellow1,
  2. Theo Vos, professor1
  1. 1University of Queensland, School of Population Health, Herston, QLD 4006, Australia
  1. l.veerman{at}uq.edu.au

    The National Institute for Health and Clinical Excellence (NICE) is under heavy criticism for its osteoporosis guidelines.1 The National Osteoporosis Society argues that many people who would benefit from treatment are not treated and left with unnecessarily and unethically high fracture risks.

    The debate is, however, confused by the combination of two factors: the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe